9
views
0
recommends
+1 Recommend
2 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Cardioprotection conferred by rooibos (Aspalathus linearis): A mini review to highlight a potential mechanism of action

      research-article
      South African Journal of Science
      Academy of Science of South Africa
      South Africa, medicinal plants, novel heart drugs, heart research

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          A number of cardioprotective interventions have been identified throughout the years, and these include the use of natural antioxidants in sources like rooibos (Aspalathus linearis) tea. Recent studies have demonstrated that rooibos (either its isolated components or the crude rooibos extract/tea) confers cardioprotection in diabetic cardiomyopathy and myocardial ischaemic injury. In addition, a clinical study has shown that regular rooibos consumption reduces the risk for cardiovascular disease in adults. However, rooibos is currently not considered an official treatment against cardiac disease, mainly because the underlying mechanisms for rooibos-induced cardioprotection are not fully elucidated. Physiological actions of rooibos must be well investigated before rooibos can be used in a clinical setting as adjunct treatment for patients with heart disease. Thus, research to delineate the underlying mechanisms of rooibos-induced cardioprotection is key. In the light of the aforementioned, the available literature on rooibos-induced cardioprotection is reviewed here, highlighting the fact that rooibos preserves and maintains cardiac energy homeostasis. It is postulated that rooibos activates an AMPK-GLUT-4 glucose oxidation (cardiac energy-shortage sensing) pathway to shift cardiac energy usage, thereby conferring cardioprotection. SIGNIFICANCE: •It is hypothesised that rooibos may alter the way in which the human heart uses energy and oxygen, in order to protect the heart against disease. The heart's mitochondria are responsible for the heart's energy processes, and therefore are most likely involved in rooibos-induced cardioprotection. •Cardioprotection conferred by rooibos is likely via an AMPK-GLUT-4 glucose oxidation pathway. •The mechanism of cardioprotection is important for future studies investigating how rooibos alters cardiac mitochondria. •The more information gathered about the underlying mechanisms of rooibos, the easier it will be to recommend rooibos as an official cardioprotective intervention in patients with heart disease.

          Related collections

          Most cited references52

          • Record: found
          • Abstract: found
          • Article: not found

          The Randle cycle revisited: a new head for an old hat.

          In 1963, Lancet published a paper by Randle et al. that proposed a "glucose-fatty acid cycle" to describe fuel flux between and fuel selection by tissues. The original biochemical mechanism explained the inhibition of glucose oxidation by fatty acids. Since then, the principle has been confirmed by many investigators. At the same time, many new mechanisms controlling the utilization of glucose and fatty acids have been discovered. Here, we review the known short- and long-term mechanisms involved in the control of glucose and fatty acid utilization at the cytoplasmic and mitochondrial level in mammalian muscle and liver under normal and pathophysiological conditions. They include allosteric control, reversible phosphorylation, and the expression of key enzymes. However, the complexity is formidable. We suggest that not all chapters of the Randle cycle have been written.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Diabetic cardiomyopathy, causes and effects.

            Diabetes is associated with increased incidence of heart failure even after controlling for coronary artery disease and hypertension. Thus, as diabetic cardiomyopathy has become an increasingly recognized entity among clinicians, a better understanding of its pathophysiology is necessary for early diagnosis and the development of treatment strategies for diabetes-associated cardiovascular dysfunction. We will review recent basic and clinical research into the manifestations and the pathophysiological mechanisms of diabetic cardiomyopathy. The discussion will be focused on the structural, functional and metabolic changes that occur in the myocardium in diabetes and how these changes may contribute to the development of diabetic cardiomyopathy in affected humans and relevant animal models.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              AMPK: energy sensor and survival mechanism in the ischemic heart.

              AMP-activated protein kinase (AMPK) is a critical regulator of cellular metabolism and plays an important role in diabetes, cancer, and vascular disease. In the heart, AMPK activation is an essential component of the adaptive response to cardiomyocyte stress that occurs during myocardial ischemia. During ischemia-reperfusion, AMPK activation modulates glucose and fatty acid metabolism, mitochondrial function, endoplasmic reticulum (ER) stress, autophagy, and apoptosis. Pharmacological activation of AMPK prevents myocardial necrosis and contractile dysfunction during ischemia-reperfusion and potentially represents a cardioprotective strategy for the treatment of myocardial infarction. This review discusses novel mechanisms of AMPK activation in the ischemic heart, the role of endogenous AMPK activation during ischemia, and the potential therapeutic applications for AMPK-directed therapy.
                Bookmark

                Author and article information

                Contributors
                Role: ND
                Journal
                sajs
                South African Journal of Science
                S. Afr. j. sci.
                Academy of Science of South Africa (Pretoria, Gauteng, South Africa )
                0038-2353
                1996-7489
                August 2019
                : 115
                : 7-8
                : 1-4
                Affiliations
                [01] Stellenbosch orgnameStellenbosch University orgdiv1Department of Biomedical Sciences orgdiv2Division of Medical Physiology South Africa
                Article
                S0038-23532019000400015
                10.17159/sajs.2019/4653
                e146afeb-3dc6-4438-aadd-102566cc35f9

                This work is licensed under a Creative Commons Attribution 4.0 International License.

                History
                : 10 April 2019
                : 08 March 2018
                : 12 April 2019
                Page count
                Figures: 0, Tables: 0, Equations: 0, References: 60, Pages: 4
                Product

                SciELO South Africa

                Categories
                Review Articles

                novel heart drugs,heart research,South Africa,medicinal plants

                Comments

                Comment on this article